Branched Oncolytic Peptides Target HSPGs, Inhibit Metastasis, and Trigger the Release of Molecular Determinants of Immunogenic Cell Death in Pancreatic Cancer.
Alessandro Rencinai, Eva Tollapi, Giulia Marianantoni, Jlenia Brunetti, Tania Henríquez, Alessandro Pini, Luisa Bracci, Chiara Falciani
This paper introduces two branched oncolytic peptides, BOP7 and BOP9, which target HSPGs, inhibit metastasis, and induce immunogenic cell death in pancreatic cancer cells.
Frontiers in Molecular Biosciences · Oct 2, 2024Peer-reviewedBiochemistry